Xvivo Perfusion AB

Xvivo Perfusion AB

200.60
SEK
+4.60
(+2.35%)
4.09EPS
53.83P/E
6.94BMarket Cap
Jan 28Next Earn

Xvivo Perfusion AB Documents

Q2 FY2021 · Press release

2 pages

Read Xvivo Perfusion AB's results firsthand

Preview this press release
Create a free account to start reading

Full documents are included with Professional

Q2 FY2021 documents